Clinical Trial Detail

NCT ID NCT00003553
Title Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications

renal cell carcinoma

Therapies

Cyclophosphamide + Fludarabine

Cyclosporine

Mycophenolate mofetil

Methotrexate

Age Groups: senior adult

No variant requirements are available.